Tuppy, thanks for one of the stupidest posts I've read in awhile (Russ, your post wasn't far behind Tuppy's)
"They need to be held accountable..."
Correct and here is what I hold them accountable for re. regenerative tech.
- Compounding CardioCel sales by approx 50% (every half!) from $1 million in the 2nd half CY2014 to $1.6 million in the 1st half CY2015 to $2.4 million in the 2nd half CY2015.
(Tups, perhaps you're more knowledgeable in this area than me, please show us JUST ONE other medical devices company which is compounding sales by 50% half on half, or if you can't find one current company doing it how about one in the past... I'm not trying to be funny, I'm genuinely interested!)
- Almost matching FULL FY15 CardioCel sales of aprox $2.6 million in ONLY THE FIRST HALF of FY16.
- Getting CardioCel into over 145 of the world's top centres around the world just a couple of years after CE mark and FDA approval.
- Getting CardioCel implanted in over 4000 patients just a couple of years after CE Mark and FDA approval.
(This in the notoriously conservative market of cardiac surgery.)
- Getting CardioCel used for aortic valve repairs/reconstructions, the toughest of all valves and one which no native tissue can be used reliably to repair/reconstruct, this is why surgeons replace! Until now they had no choice. They've always wanted to repair/reconstruct and now they can.
- Getting CardioCel advocated and promoted across numerous studies by many of the world's top surgeons here, in The US and in Europe.
- Getting our second product VascuCel being trialed by top US centre last year.
-Getting VacuCel on the verge of commercialisation now.
- Here is another thing I hold management accountable for, doing a poor job in market releases promoting the company and product enough. Whilst they have an incredible grasp on the regenerative surgical world they lack understanding of how myopic and short sighted our own market is, how impatient it is, how our market needs to have its hand held and be constantly updated with new news and info. This, they have failed in.
I also hold management accountable for many remarkable achievements on the vaccine front although this post is already long enough.
AHZ Price at posting:
45.0¢ Sentiment: Buy Disclosure: Held
(20min delay)